MONICA CHEN to Mitogen-Activated Protein Kinase Kinases
This is a "connection" page, showing publications MONICA CHEN has written about Mitogen-Activated Protein Kinase Kinases.
Connection Strength
0.057
-
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study. Lancet Oncol. 2025 Oct; 26(10):1357-1369.
Score: 0.057